Get the Stockscreener App
1.57
5.42%
-0.09
Biomea Fusion Inc stock is traded at $1.57, with a volume of 1.06M.
It is down -5.42% in the last 24 hours and down -8.72% over the past month.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
See More
Previous Close:
$1.66
Open:
$1.64
24h Volume:
1.06M
Relative Volume:
0.46
Market Cap:
$58.99M
Revenue:
-
Net Income/Loss:
$-144.01M
P/E Ratio:
-0.3915
EPS:
-4.01
Net Cash Flow:
$-113.02M
1W Performance:
-14.21%
1M Performance:
-8.72%
6M Performance:
-62.44%
1Y Performance:
-72.70%
1-Day Range:
$1.53
$1.65
1-Week Range:
$1.53
$1.85
52-Week Range:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Name
Biomea Fusion Inc
Sector
Industry
Phone
(650) 980-9099
Address
900 MIDDLEFIELD ROAD, REDWOOD CITY
Compare BMEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.57 | 94.66M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Resumed | Piper Sandler | Overweight |
| Oct-09-24 | Initiated | Edward Jones | Buy |
| Sep-27-24 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Sep-27-24 | Upgrade | Truist | Hold → Buy |
| Aug-29-24 | Initiated | CapitalOne | Overweight |
| Jun-11-24 | Downgrade | Truist | Buy → Hold |
| Jun-07-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-06-24 | Initiated | Truist | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Jun-26-23 | Downgrade | Jefferies | Buy → Hold |
| May-12-23 | Initiated | Barclays | Overweight |
| Mar-29-23 | Reiterated | Oppenheimer | Outperform |
| Mar-28-23 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-23 | Initiated | Citigroup | Buy |
| Jun-02-22 | Resumed | H.C. Wainwright | Buy |
| Jan-12-22 | Initiated | H.C. Wainwright | Buy |
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Jefferies | Buy |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Biomea Fusion Inc Stock (BMEA) Latest News
What is the dividend policy of Biomea Fusion Inc. stockFree Stock Tracker With Low Risk - jammulinksnews.com
Is Biomea Fusion Inc. a growth stock or a value stockBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com
Is it the right time to buy Biomea Fusion Inc. stockTop Growth Tips For Consistent Profits - jammulinksnews.com
Will Biomea Fusion Inc. benefit from macro trendsTriple Return Setup With Risk Control Explained - metal.it
How volatile is Biomea Fusion Inc. stock compared to the marketStock Market Forecasts From AI Tools - jammulinksnews.com
Key resistance and support levels for Biomea Fusion Inc.Fast Exit and Entry Strategy Guide Offered - metal.it
How Biomea Fusion Inc. stock performs during market volatilityStock Market Watch With Alerts Shows Unusual Activity - metal.it
Quant Tools Rank Biomea Fusion Inc. as High Risk High RewardBreakout Entry Signal Confirmation Tool Used - metal.it
Recovery Setup Building in Biomea Fusion Inc. Experts SayPattern Detection for Entry Confirmation Enabled - metal.it
Why Biomea Fusion Inc. stock attracts strong analyst attentionPattern Breakout Entry Stock Forecast in Focus - metal.it
Biomea Fusion Inc. Hits Oversold Level on RSI IndicatorWeekly Stock Watch With Growth Focus Expanded - metal.it
What markets is Biomea Fusion Inc. expanding into Is MAMO stock a good long term investment option - jammulinksnews.com
Does Biomea Fusion Inc. stock perform well during market downturnsBuild a portfolio that stands the test of time - jammulinksnews.com
What makes Biomea Fusion Inc. stock price move sharplyHigh-octane gains - jammulinksnews.com
Biomea Fusion BMEA 2025Q2 Earnings Preview Downside Risk Amid EPS Estimate Revisions - AInvest
Published on: 2025-07-28 06:30:27 - jammulinksnews.com
Is Biomea Fusion Inc. a Top Dividend Stock to Watch in 2025Free Smart Investment Opportunities - metal.it
Is Biomea Fusion Inc. stock overvalued or undervaluedExponential return rates - jammulinksnews.com
What analysts say about Biomea Fusion Inc. stockTriple-digit returns - PrintWeekIndia
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know - MSN
Biomea Fusion Appoints Julianne Averill to its Board of Directors - The Manila Times
Biomea Fusion appoints Julianne Averill to board of directors - Investing.com Australia
Press Release: Biomea Fusion Appoints Julianne Averill to Its Board of Directors - 富途牛牛
What drives Biomea Fusion Inc. stock priceRapid-fire capital growth - Autocar Professional
Biomea Fusion Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com
Is Biomea Fusion Inc. a good long term investmentBreakthrough capital growth - jammulinksnews.com
Citigroup Lowers Biomea Fusion Price Target to $9.00 Amid "Buy" Rating - AInvest
Citigroup Has Lowered Expectations for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
Citigroup downgrades Biomea Fusion to Buy with a reduced PT of $9. - AInvest
While institutions invested in Biomea Fusion, Inc. (NASDAQ:BMEA) benefited from last week's 15% gain, retail investors stood to gain the most - Yahoo Finance
Biomea Fusion Inc Stock (BMEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):